Bay Colony Advisory Group, Inc D Abbott Laboratories Transaction History

Bay Colony Advisory Group, Inc D

$580 Million
Q2 2024

A detailed history of Bay Colony Advisory Group, Inc D transactions in Abbott Laboratories stock. As of the latest transaction made, Bay Colony Advisory Group, Inc D holds 17,224 shares of ABT stock, worth $1.94 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

17,224

Previous 16,854 2.2%

Holding current value

$1.94 Million

Previous $1.92 Million 6.58%

% of portfolio

0.31%

Previous 0.35%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	BUY	$100.73 - $112.44 $37,270 - $41,602	370 Added 2.2%	17,224 $1.79 Million
Q1 2024 Apr 30, 2024	SELL	$109.52 - $120.96 $13,361 - $14,757	-122 Reduced 0.72%	16,854 $1.92 Million
Q4 2023 Jan 29, 2024	BUY	$90.19 - $110.4 $36,256 - $44,380	402 Added 2.43%	16,976 $1.87 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $40,122 - $48,140	-420 Reduced 2.47%	16,574 $1.61 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $4,635 - $5,165	-46 Reduced 0.27%	16,994 $1.85 Million
Q1 2023 Apr 27, 2023	SELL	$96.86 - $114.01 $59,278 - $69,774	-612 Reduced 3.47%	17,040 $1.73 Million
Q4 2022 Feb 01, 2023	BUY	$95.06 - $111.52 $42,016 - $49,291	442 Added 2.57%	17,652 $1.94 Million
Q3 2022 Oct 27, 2022	BUY	$96.76 - $112.03 $51,186 - $59,263	529 Added 3.17%	17,210 $1.67 Million
Q2 2022 Aug 08, 2022	BUY	$102.07 - $123.37 $47,972 - $57,983	470 Added 2.9%	16,681 $1.82 Million
Q1 2022 Apr 28, 2022	SELL	$114.02 - $139.04 $26,224 - $31,979	-230 Reduced 1.4%	16,211 $1.92 Million
Q4 2021 Jan 28, 2022	SELL	$115.53 - $141.46 $32,694 - $40,033	-283 Reduced 1.69%	16,441 $2.31 Million
Q3 2021 Nov 02, 2021	SELL	$116.66 - $129.06 $6,416 - $7,098	-55 Reduced 0.33%	16,724 $1.98 Million
Q2 2021 Jul 22, 2021	BUY	$105.79 - $124.53 $45,912 - $54,046	434 Added 2.66%	16,779 $1.95 Million
Q1 2021 May 13, 2021	BUY	$108.84 - $128.23 $409,564 - $482,529	3,763 Added 29.91%	16,345 $1.96 Million
Q4 2020 Feb 02, 2021	BUY	$105.0 - $114.42 $172,200 - $187,648	1,640 Added 14.99%	12,582 $1.38 Million
Q3 2020 Nov 25, 2020	BUY	$91.64 - $111.29 $22,635 - $27,488	247 Added 2.31%	10,942 $1.19 Million
Q2 2020 Jul 23, 2020	SELL	$76.57 - $98.0 $17,151 - $21,952	-224 Reduced 2.05%	10,695 $978,000
Q1 2020 Apr 17, 2020	SELL	$62.82 - $91.86 $16,019 - $23,424	-255 Reduced 2.28%	10,919 $862,000
Q4 2019 Jan 28, 2020	SELL	$78.51 - $87.4 $14,838 - $16,518	-189 Reduced 3.77%	4,823 $419,000
Q4 2019 Jan 28, 2020	BUY	$78.51 - $87.4 $498,617 - $555,077	6,351 Added 131.68%	11,174 $1.03 Million
Q3 2019 Oct 25, 2019	BUY	$81.84 - $88.74 $410,182 - $444,764	5,012 New	5,012 $419,000
Q1 2019 Apr 30, 2019	SELL	$66.22 - $80.06 $447,183 - $540,645	-6,753 Closed	0 $0
Q4 2018 Jan 29, 2019	BUY	$65.56 - $74.27 $72,771 - $82,439	1,110 Added 19.67%	6,753 $488,000
Q3 2018 Nov 05, 2018	BUY	$60.81 - $73.36 $275,590 - $332,467	4,532 Added 407.92%	5,643 $414,000
Q2 2018 Aug 09, 2018	BUY	$57.57 - $63.54 $63,960 - $70,592	1,111 New	1,111 $68,000

Others Institutions Holding ABT

# of Institutions

3,137

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bay Colony Advisory Group, Inc D, based on Form 13F filings with the SEC.

News

Stay updated on Bay Colony Advisory Group, Inc D with notifications on news.

Account

Bay Colony Advisory Group, Inc D Abbott Laboratories Transaction History